Consensus Novartis AG

Equities

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 16:30:51 13/02/2026 GMT			5-day change	1st Jan Change
125.14 ^CHF	+1.08%		+4.32%	+14.18%

02-13	Sector Update: Health Care Stocks Advance Late Afternoon	MT
02-13	Sector Update: Health Care Stocks Higher Friday Afternoon	MT

Evolution of the Average Target: Novartis AG

Evolution of the Target Price: Novartis AG

Changes in Analyst Recommendations: Novartis AG

b78cc7a519927880b3bb2f.9WAOhAN-o7tGW94ESGCKk5SlmFZQTIOqLhZX2BtfzKw.tjhZszIv9c4ZK700eFfJ6f__wQUifvHuGVVitVUX-u6gWD7KbBnvzyA46g~57e0ad78ff62acfb91bf7663be23df26

Analysts' recommendations: Novartis AG

02-12	NOVARTIS AG : Deutsche Bank maintains a Buy rating	ZD
02-12	NOVARTIS AG : JP Morgan gives a Buy rating	ZD
02-12	Swiss stocks - Factors to watch on February 12	RE
02-09	NOVARTIS AG : Reduced to Neutral by DZ Bank	ZD
02-06	NOVARTIS AG : UBS reiterates its Neutral rating	ZD
02-05	NOVARTIS AG : Deutsche Bank reaffirms its Buy rating	ZD
02-04	Novartis: Markets happy with Novartis's delivery
02-04	Novartis Reaffirmed at Buy as BofA Notes Drug Pipeline Shifting Balance	MT
02-04	NOVARTIS AG : UBS reaffirms its Neutral rating	ZD
02-04	NOVARTIS AG : Goldman Sachs keeps a Sell rating	ZD
02-04	NOVARTIS AG : Jefferies is Neutral	ZD
02-04	Swiss stocks - Factors to watch on February 4	RE
01-27	Citi Kicks Off Novartis Coverage at Buy	MT
01-21	NOVARTIS AG : Gets a Sell rating from Goldman Sachs	ZD
01-16	NOVARTIS AG : UBS sticks Neutral	ZD
01-16	NOVARTIS AG : Deutsche Bank keeps its Buy rating	ZD
01-15	NOVARTIS AG : Barclays remains Neutral	ZD
01-14	Swiss stocks - Factors to watch on January 14	RE
01-08	NOVARTIS AG : Berenberg reiterates its Neutral rating	ZD
01-07	NOVARTIS AG : Barclays Upgrades to Neutral	ZD
01-05	NOVARTIS AG : Gets a Buy rating from JP Morgan	ZD
12-23	Morningstar Downgrades Novartis to Sell	MT
12-23	NOVARTIS AG : Receives a Buy rating from JP Morgan	ZD
12-17	Sector Update: Tech Stocks Fall Late Afternoon	MT
12-16	NOVARTIS AG : Gets a Buy rating from Deutsche Bank	ZD

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

162.83USD

Average target price

148.70USD

Spread / Average Target

-8.68%

High Price Target

175.54USD

Spread / Highest target

+7.80%

Low Price Target

115.60USD

Spread / Lowest Target

-29.01%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

JPMORGAN	Richard Vosser
DZ BANK	Elmar Kraus
UBS	Matthew Weston
alphavalue	Abhishek Raval
GOLDMAN SACHS	James Quigley
JEFFERIES
Citigroup
DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
BARCLAYS	James Gordon
BERENBERG	Luisa Hector
Morningstar
Morgan Stanley
AlphaValue/Baader Europe
BERNSTEIN RESEARCH	Florent Cespedes
Intron Health
Bank Vontobel AG
BNP Paribas Exane
DA Davidson
HSBC
Octavian AG
Jefferies & Co.
Deutsche Bank Securities
Baader Bank
Berenberg Bank
BMO Capital
Kepler Capital Markets
Societe Generale
Redburn
Stifel Nicolaus
BNP Paribas
Barrington Research
International Strategy & Investment Group
Credit Suisse
ODDO BHF
Zacks Equity Research
Bank of America Securities/Merrill Lynch
Kepler Cheuvreux
Wolfe Research
AltaCorp Capital
DEUTSCHE BANK	Emmanuel Papadakis
Exane BNP Paribas
Bryan, Garnier & Co.
Moody's Investors Service
Dundee
Exane BNP
Bernstein
Argus
Cowen
BRYAN GARNIER	Eric Le Berrigaud
LIBERUM CAPITAL	Graham Doyle
BANK OF AMERICA (BOFA)	Graham Parry